[July 1, 2026] Why Telehealth Isn’t Just A Video Call. Access to care remains one of healthcare’s biggest challenges—especially in physical therapy, where patients often travel hours for a single appointment.

In this episode of Med Tech Gurus, we sit down with Dr. Ashok Gupta, founder and CEO of TheraNow, a rapidly growing virtual physical therapy platform that has treated more than 70,000 patients nationwide through a network of over 400 therapists.

Ashok’s journey began on the front lines as a physical therapist working in rural communities and VA hospitals, where he repeatedly saw patients abandon treatment simply because access to care was too difficult. That experience led him to ask a bold question: if mental health therapy can be delivered virtually, why not physical therapy?

In this conversation, Ashok shares how TheraNow built a telehealth platform that works inside healthcare workflows—not outside them. We explore why many virtual care startups fail, how AI-powered clinical documentation can improve therapist productivity, and what it takes to scale a digital health company while partnering with major health systems.

Ashok also discusses achieving Joint Commission accreditation, integrating with complex EHR environments, and building operational infrastructure that supports both clinicians and patients.

If you're interested in telehealth innovation, digital health startups, AI in healthcare, physical therapy, or healthcare workflow design, this episode offers practical insights on building virtual care platforms that actually work.

[June 24, 2026] Robots Are Coming To The Cath Lab. What if the future of interventional cardiology isn’t just better devices—but robotic precision?

In this episode of Med Tech Gurus, we sit down with Dr. Philippe Bencteux, founder and president of RoboCath, a pioneering company developing robotic platforms designed to transform cardiovascular and neurovascular interventions.

A neuroradiologist turned entrepreneur, Dr. Bencteux launched RoboCath after witnessing how access to specialized vascular expertise can determine whether patients live or die—particularly in hospitals lacking advanced interventional capabilities. His vision: bring robotic precision and eventually remote care to life-saving endovascular procedures.

We explore the evolution of RoboCath’s robotic systems, including the R1 platform, which demonstrated more than 98% technical success in multicenter studies, and the company’s next-generation system now entering first-in-human trials for coronary artery disease.

Dr. Bencteux shares how robotics can dramatically improve physician safety by reducing radiation exposure and physical strain in the cath lab, while also increasing procedural precision and enabling more complex interventions.

If you're interested in robotic surgery, interventional cardiology innovation, digital health, AI-driven medical devices, or the future of remote healthcare, this episode offers a fascinating look at how robotics could reshape the next era of cardiovascular treatment.

[June 17, 2026] Data Isn’t Strategy. AI can analyze data faster than any human—but strategy still requires judgment.

In this episode of Med Tech Gurus, we sit down with Joe Luminiello, Founder and CEO of RCG Intel, a competitive intelligence firm operating at the intersection of healthcare, biopharma, and AI-driven decision making. With more than 40 years of life sciences leadership experience—including helping launch Takeda’s Canadian business and leading a 650-person commercial organization responsible for over $1B in annual sales—Joe brings a unique perspective on what separates data from real strategic insight.

Joe explains why many life sciences companies struggle to translate information into action. While AI can rapidly analyze clinical data, market signals, and competitive activity, it cannot replace the contextual intelligence that comes from human conversations with physicians, key opinion leaders, and frontline healthcare professionals.

We explore how commercial teams can avoid the common disconnect between product development and market strategy, why cross-functional communication is critical for successful product launches, and how companies can use AI to enhance—not replace—human decision-making.

If you're a MedTech founder, biotech executive, investor, or commercial leader navigating AI, competitive intelligence, and product commercialization, this episode offers powerful insights into turning data into strategy and strategy into execution.

[June 10, 2026] Why Most Radiology AI Fails. AI can detect lung nodules in milliseconds—so why hasn’t radiology been transformed?

In this episode of Med Tech Gurus, we sit down with Khan Siddiqui, radiologist, serial entrepreneur, and CEO of HOPPR, to unpack why most AI tools in medical imaging struggle to survive beyond pilot studies.

Dr. Siddiqui explains that detection isn’t the real problem—workflow is. As imaging volumes surge and radiologist shortages intensify, AI must deliver measurable ROI in time savings, reporting efficiency, and reduced cognitive load. Tools that add clicks or increase reading time simply won’t scale.

We explore HOPPR’s AI-native platform, which accelerates model development, enables local fine-tuning, and integrates AI directly into existing clinical workflows. Khan also shares powerful lessons on fundraising, identifying “hair-on-fire” customers, building A-player teams, and scaling innovation responsibly in regulated healthcare environments.

If you care about AI in healthcare, radiology innovation, or moving from hype to real-world adoption, this episode delivers practical insight from one of the field’s pioneers.

[June 3, 2026] Rewriting the Rules of Pediatric Lumbar Puncture. What if one of pediatrics’ most common emergency procedures hasn’t meaningfully evolved in over a century?

In this episode of Med Tech Gurus, we sit down with Bob Cooper, CEO of SMoLTAP, to explore how a simple but powerful positioning innovation is transforming infant lumbar punctures.

For decades, pediatric spinal taps have relied on manual restraint, inconsistent positioning, and high failure rates—often leading to repeat attempts, unnecessary hospital admissions, and increased stress for clinicians and families. SMoLTAP’s positioning cradle stabilizes infants in a consistent seated posture, improving first-stick success rates, reducing procedural time, and minimizing the need for sedation.

Bob shares the origin story—from a frustrating clinical moment at Brown University to adoption in over 100 hospitals—and dives into the realities of pediatric medical device commercialization. We explore specialty distribution strategies, navigating value analysis committees, building ROI calculators, and scaling capital-efficiently in a challenging healthcare market.

This episode is a powerful example of how human-centered design, operational insight, and disciplined execution can change the standard of care.

[May 27, 2026] The Human Side of Medtech Innovation. Why do so many MedTech innovations fail to gain traction—even when the technology works exactly as designed?

In this episode of Med Tech Gurus, we’re joined by Erin Rollenhagen, Founder and CEO of People-Friendly Tech, UX strategist, and author of Love at First Launch. With experience leading over 200 successful technology launches across healthcare and other regulated industries, Erin brings a unique perspective on what truly drives product adoption.

Erin explains why usability and emotional connection often matter more than features alone—and why success depends on how both clinicians and patients feel when interacting with new technology. We explore how companies can preserve the original vision behind their innovations while navigating compliance, scaling challenges, and evolving market demands.

From designing onboarding experiences that build trust to using AI thoughtfully without overwhelming users, Erin shares how MedTech leaders can create solutions that align with real-world workflows and deliver meaningful outcomes.

If you’re a founder, executive, or investor looking to improve clinical adoption and scale innovation without losing the magic of your original idea, this episode offers practical insights into building technology people actually want to use.

[May 20, 2026] Fixing the Hidden Bottleneck in Healthcare. Why do hospitals invest millions in clinical innovation—yet still struggle to move patients down the hall?

In this episode of Med Tech Gurus, we sit down with Dr. David Crabb, emergency physician and CEO of Rovex, to explore one of healthcare’s most overlooked operational challenges: patient transport. Drawing on his dual experience in frontline emergency medicine and clinical informatics, Dr. Crabb shares how delays in moving patients between departments can quietly impact throughput, staff workload, and ultimately patient outcomes.

At Rovex, Dr. Crabb is leading the development of an autonomous mobile robot designed to attach to standard hospital stretchers—safely transporting patients while reducing delays, minimizing staff injuries, and helping clinicians work at the top of their license. We discuss how physical AI and robotics are moving beyond the digital world to address real-world inefficiencies inside hospitals.

From building trust in AI-driven systems to navigating adoption challenges in complex care environments, this episode explores what it takes to introduce an entirely new category of medical technology—and why solving logistical problems may be the key to unlocking better care delivery.

[May 13, 2026] The Product Adoption Lie: Why Great Medtech Fails to Scale. Why do so many breakthrough MedTech products fail — even when the technology works?

In this episode of Med Tech Gurus, we’re joined by Holley Miller, Founder and President of Grey Matter Marketing and one of the most direct, no-nonsense voices in healthcare commercialization today. With nearly three decades in life sciences — from the early days of surgical robotics to advising CEOs, boards, and investors — Holley has helped create more than $4.5 billion in enterprise value by doing one thing differently: designing adoption before launch.

Holley is the architect of what she calls the Product Adoption Lie — the dangerous belief that better products automatically win. In this conversation, she explains why most launches fail not because the product is weak, but because the market was never taught to change its beliefs or behavior. We explore why adoption must be engineered, how category design replaces traditional go-to-market playbooks, and why alignment across clinical, regulatory, and commercial teams is essential to changing the standard of care.

If you’re a founder, executive, or investor trying to scale innovation — not just launch a product — this episode delivers a hard truth and a clear roadmap for building something the market can’t ignore.

[May 6, 2026] When Every Minute is Critical: Scaling AI to Save Stroke Patients. What if frontline clinicians everywhere had instant access to expert-level stroke imaging — no matter where a patient arrives?

In this episode of Med Tech Gurus, we’re joined by Michalis Papadakis, CEO and Co-Founder of Brainomix, an Oxford University spin-out using AI to transform how stroke is diagnosed and treated. With a background in neuroscience from Imperial College London, UCL, and the University of Oxford, Michalis built Brainomix with a singular mission: ensure patients don’t miss out on life-saving stroke treatments due to delays or lack of imaging expertise.

Under his leadership, Brainomix developed Brainomix 360 Stroke, the world’s first fully automated AI imaging suite for stroke care — now deployed in more than 30 countries, backed by 50+ clinical publications, and processing patient scans in minutes with results delivered in under sixty seconds. In this conversation, we explore how starting with a true clinical unmet need, relentless evidence generation, and seamless workflow integration enabled Brainomix to scale globally and materially improve patient outcomes.

If you care about AI in healthcare, stroke innovation, clinical adoption, or scaling medtech from academia to enterprise, this is a blueprint worth hearing.

[April 29, 2026] From Signal to Scale: Turning Medtech Data into Growth. Why do so many great MedTech products stall after launch — even when the data is there?

In this episode of Med Tech Gurus, we’re joined by Amy Brouhle, Vice President of Strategic Business Development at S2N Health. A former emergency department nurse turned commercialization leader, Amy brings more than 20 years of experience spanning clinical care, GPO strategy, national accounts, and MedTech growth. Her career includes senior roles at Vizient, Hillrom, and GE Healthcare, giving her a rare, end-to-end view of how innovation actually gets adopted — or stuck.

At S2N Health, Amy helps MedTech companies cut through the noise of fragmented data and turn insight into action. We explore why most organizations don’t have a data problem — they have an insight problem — and how aligning sales, marketing, and strategy around the right signals can unlock utilization, accelerate adoption, and improve investor confidence.

From GPO dynamics and channel strategy to AI-powered targeting, territory planning, and go-to-market execution, Amy shares practical lessons every founder and commercial leader needs to hear. If you’re trying to translate innovation into revenue and scale, this is a conversation you won’t want to miss.

[April 22, 2026] From Acute Care to Continuous Care. Why has healthcare resisted digital transformation longer than almost any other industry?

In this episode of Med Tech Gurus, we’re joined by Mariano García-Valiño, four-time entrepreneur, digital health innovator, and CEO of AXENYA—recently named one of the world’s best digital health companies by Newsweek. Mariano has built, scaled, and exited billion-dollar healthcare companies by combining technology, data, and human-centered design to tackle chronic disease at scale.

Mariano is also the author of Inedible, where he argues that modern healthcare is still built for acute illness, not the chronic conditions driving today’s costs and outcomes. In this conversation, we explore why software alone isn’t enough, how AI and continuous care models unlock real impact, and what it actually takes to scale health tech in complex, regulated markets.

From leadership and entrepreneurship to AI-enabled care delivery, Mariano shares hard-earned lessons on building companies with both scale and purpose. If you care about digital health, healthcare transformation, or meaningful innovation, this is a conversation you won’t want to miss.

[April 15, 2026] Beating the Clock: Rethinking Brain Tumor Care. What if the most dangerous part of brain tumor treatment isn’t the surgery… but the wait that comes after it?

In this episode of Med Tech Gurus, we sit down with Dr. Michael Garcia, Chief Medical Officer and Head of Clinical Development at GT Medical Technologies, and one of the leading voices reshaping how we treat brain tumors. Dr. Garcia leads the clinical strategy behind GammaTile® — an implantable, bioabsorbable device that delivers targeted radiation from inside the brain immediately after surgery, eliminating the dangerous 3–6 week delay where tumors often begin to grow back.

Under his leadership, GT Medical has reported powerful interim clinical data showing GammaTile can reduce the risk of recurrence or death by more than 50% compared to standard of care — with no increase in safety concerns. Today, more than 150 leading cancer centers are using this technology, changing not only outcomes, but something equally important: patient experience. Less anxiety. Fewer treatment delays. Fewer logistical burdens. More hope.

Dr. Garcia shares the science, the strategy, and the deeply personal mission behind this innovation — along with insights on clinical trial design, multidisciplinary collaboration, and building medtech that truly serves patients. If you care about oncology, neurosurgery, innovation with purpose, or patient-centered design, this is a conversation you won’t want to miss.

[April 8, 2026] Stickers That Can Save Lives: The Future of Microwearable Health Monitoring. What happens when rocket-science precision meets frontline healthcare?

In this episode of Med Tech Gurus, we sit down with Professor Mark Kendall, Founder & CEO of WearOptimo and one of the world’s most visionary biomedical innovators. A former rocket scientist turned medtech pioneer, Mark has already transformed vaccine delivery with groundbreaking platforms like PowderJet and Vaxxas. Now, he’s doing it again — this time with a revolutionary micro-wearable sensor designed to pull high-fidelity biosignals directly from the skin without painful needles or invasive hardware.  

Mark explains how WearOptimo’s sticker-like microneedle patch, built using cutting-edge manufacturing techniques that scale to tens of millions of units, is redefining what wearables can do. The first target? Hydration monitoring — solving a problem so widespread it quietly reduces life expectancy and affects elite athletes, surgical outcomes, and everyday health. From scalable manufacturing and AI-enabled biomarker intelligence, to building elite teams and navigating fundraising, Mark delivers powerful lessons on innovation, leadership, and building technologies that truly matter. 

If you’re passionate about the future of wearable medicine, platform technology, and designing solutions that actually reach the real world, this conversation is one you won’t want to miss.

[April 1, 2026] From Data to Decisions: Powering Growth in MedTech. What if getting breakthrough devices to the right patients wasn’t a guessing game — but a data-driven science?

In this episode of Med Tech Gurus, we sit down with Mike Monovoukas, CEO and Co-Founder of AcuityMD, one of the fastest-growing platforms in MedTech. Mike shares how his team is turning mountains of messy healthcare data into clear, actionable insights — helping innovators pinpoint the right physicians, facilities, and patient populations, and transforming how devices reach the people who need them most.

We explore how AcuityMD is powering precision targeting through AI, why democratizing market intelligence helps level the playing field for new entrants, and how smarter commercialization can unlock access for underserved communities — including their work helping EPI bring the Alpha-Stim device to veterans struggling with pain, insomnia, and anxiety.  

From designing platforms built specifically for MedTech, to making complex data simple for frontline sales teams, to reshaping how companies scale, Mike delivers a masterclass in building for the future of commercialization — where evidence, empathy, and AI come together.

[March 25, 2026] Why Patients are Losing Trust in Healthcare: The MAHA Signal Explained. What if the Make America Healthy Again (MAHA) movement isn’t political noise—but a powerful signal that patient expectations are fundamentally changing?

In this episode of Med Tech Gurus, we sit down with Noël Theodosiou, CEO of Luminous, to explore the growing trust gap between life sciences companies and the patients they serve. Noël challenges leaders to move beyond a traditional “we know best” mindset and embrace a biopsychosocial, patient-centered approach to innovation.

From GLP-1 adoption trends to AI-driven health searches, we discuss why co-creation, prevention, and clearer separation between science and promotion are critical to rebuilding credibility. For founders, executives, and investors navigating today’s shifting healthcare landscape, this conversation delivers practical insight into aligning innovation with modern patient expectations.

[March 18, 2026] Engineering the Future of Wearables. In this episode of Med Tech Gurus, we sit down with Dr. Adam S. Arthur, Chief Medical Officer for Medtronic’s Neurovascular business — and one of the most influential voices in modern stroke care. With more than 20 years as a practicing neurosurgeon, clinical researcher, and academic leader, Dr. Arthur has helped redefine standards of care for ischemic stroke, hemorrhagic stroke, carotid disease, and neurovascular innovation worldwide.

Now at Medtronic, he’s leading the charge to translate real-world clinical insight into breakthrough devices that scale — from next-generation thrombectomy tools to new applications for established technologies like Onyx, and a pipeline of neurostimulation, robotics, and endovascular therapies that promise to change what’s possible for brain health.

Dr. Arthur shares powerful lessons from decades of clinical trials, including why “the devil is in the details,” how honest collaboration between physicians and industry accelerates innovation, and why failing fast is often the quickest path to breakthroughs. He also offers an exciting look at the future: remote robotics, closed-loop vagus nerve stimulation, and new ways to reach stroke patients with life-saving precision.

If you care about the future of stroke care, neurovascular devices, or scaling innovation responsibly, this episode delivers a masterclass from one of the field’s true thought leaders.

[March 11, 2026] Engineering the Future of Wearables. In this episode of Med Tech Gurus, we’re joined by John Dugas and Dr. Kevin Schwarz of Solventum Medical—two leaders pushing wearable innovation into its next era. With expertise spanning chemical engineering, materials science, synthetic biology, and global R&D, John and Kevin show how truly breakthrough wearables demand far more than clever sensors. They require world-class adhesives, smart overlays, skin-friendly materials, and device designs that survive real life—not just the lab.

They explain why longer wear time is becoming one of the biggest drivers of clinical success, how thin-film overlays can quadruple device survivability, and why understanding patient behavior is just as important as engineering excellence. From global scale to skin biomechanics, this episode delivers a powerful look at what it really takes to build wearables that stay on, stay comfortable, and stay effective.

If you’re building the next generation of chronic disease tools, diagnostics, or connected care devices — this conversation is packed with insights you won’t want to miss.

[March 4, 2026] Cracking the Code on Back Pain. In this episode of Med Tech Gurus, we welcome Neil Klompas, Chief Executive Officer of Augurex Life Sciences. With more than two decades of experience leading companies at the intersection of diagnostics, rheumatology, and translational medicine, Neil is pioneering a new era of autoimmune biomarker discovery.

Under his leadership, Augurex developed SpineStat, the world’s first blood test designed to identify axial spondyloarthritis (AxSpA)—a chronic inflammatory spinal disease that affects millions yet often goes undiagnosed for nearly a decade. By leveraging the anti-14-3-3η autoantibody in combination with CRP, SpineStat is helping clinicians detect disease earlier, prevent irreversible spinal damage, and even reduce opioid dependence through faster, targeted treatment.

Neil shares how engaging early with regulators helped Augurex earn FDA Breakthrough Device Designation, why he believes rheumatology is poised for its “oncology moment,” and how keeping his team centered on the patient journey drives innovation every day.

If you’re passionate about precision diagnostics, regulatory navigation, and building mission-driven teams, this episode is a masterclass in turning unmet medical need into measurable clinical impact.

[February 25, 2026] The Human Side of MedTech Security. What if the next medical breakthrough could be undone—not by biology—but by a hacker?

In this episode of Med Tech Gurus, we sit down with Christian Espinosa, CEO and Founder of Blue Goat Cyber, a leading medical device cybersecurity consultancy helping innovators protect patients by securing the technology behind modern healthcare. With over 30 years of experience spanning the U.S. Air Force, Department of Defense, and MedTech industry, Christian brings a rare perspective on precision, resilience, and empathy in cybersecurity

After a personal health scare revealed vulnerabilities in his own implanted device, Christian turned mission into movement—founding Blue Goat Cyber to transform cybersecurity from a regulatory afterthought into a strategic advantage

Christian shares how patient safety—not data protection—must be the heart of every cybersecurity strategy, why “bolting on” security late in development can derail innovation, and how emotional intelligence drives his leadership in high-stakes medtech environments.

Whether you’re a startup founder, RA/QA leader, or healthcare executive, this episode delivers powerful lessons on building trust, protecting patients, and creating a culture where security saves lives.

[February 18, 2026] Predicting the Unseen: AI That Saves Lives. What if artificial intelligence could spot hospital-acquired infections days before symptoms appear?

In this episode of Med Tech Gurus, we sit down with Benedikt von Thüngen, CEO and Co-Founder of Sanome, a company redefining hospital care through AI-powered clinical decision support. After enduring profound personal and professional loss, including the collapse of his seed round and the death of loved ones, Benedikt rebuilt his company around one mission—helping clinicians understand patients earlier and intervene faster

Under his leadership, Sanome became the first UK-built AI company to earn Class IIb certification, with its Memory Platform predicting infections up to 72 hours sooner than traditional methods and saving hospitals over £1.1 million at early sites.

Benedikt shares a powerful story of resilience, transparency, and innovation—proving that when data, determination, and purpose align, technology can truly save lives.